KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Historical Holders from Q3 2022 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
KALA on Nasdaq
Shares outstanding
9,818,182
Price per share
$0.5792
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
1,748,895
Total reported value
$2,688,759
% of total 13F portfolios
0%
Share change
-1,891,797
Value change
-$8,457,377
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
22
Price from insider filings
$1.38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OXFORD FINANCE LLC 16% $1,215,000 1,620,000 OXFORD FINANCE LLC 25 Nov 2025
BAKER BROS. ADVISORS LP 10% 0% $11,372,470 744,759 0% Baker Bros. Advisors LP 02 Oct 2025
SR ONE CAPITAL MANAGEMENT, LLC 4.6% -15% $5,255,568 -$1,020,402 344,176 -16% SR One Capital Management, LLC 14 Oct 2025
ADAR1 Capital Management, LLC 4.9% $1,007,478 298,955 ADAR1 Capital Management, LLC 31 Dec 2024
Point72 Asset Management, L.P. 0% -96% $407 -$742,054 257 -100% Point72 Asset Management, L.P. 30 Sep 2025
As of 30 Sep 2025, KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) has 22 institutional shareholders filing 13F forms. They hold 1,748,895 shares. of 9,818,182 outstanding shares (18%) .

Top 25 institutional shareholders own 18% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BAKER BROS. ADVISORS LP 10% 985,093 -18% 0.01% $1,507,192
Woodline Partners LP 2.5% 247,466 -18% 0% $378,623
VANGUARD GROUP INC 2.1% 210,826 +24% 0% $322,563
ADAR1 Capital Management, LLC 1.4% 141,995 -5.2% 0.02% $217,252
GEODE CAPITAL MANAGEMENT, LLC 0.69% 67,912 +20% 0% $103,949
STATE STREET CORP 0.29% 28,576 0% $43,721
BlackRock, Inc. 0.22% 21,407 +0.24% 0% $32,753
Marex Group plc 0.15% 14,500 0% $35,024
NORTHERN TRUST CORP 0.12% 11,524 +11% 0% $17,632
UBS Group AG 0.08% 8,193 +23997% 0% $12,536
Tower Research Capital LLC (TRC) 0.05% 5,076 +344% 0% $7,766
MORGAN STANLEY 0.02% 1,533 +58% 0% $2,347
BANK OF AMERICA CORP /DE/ 0.02% 1,523 +1454% 0% $2,330
Covestor Ltd 0.01% 1,264 +11% 0% $2,000
Caitong International Asset Management Co., Ltd 0.01% 736 0% $1,126
CITIGROUP INC 0.01% 721 0% $1,103
MAI Capital Management 0% 300 0% 0% $459
Steward Partners Investment Advisory, LLC 0% 120 0% 0% $184
JPMORGAN CHASE & CO 0% 51 -78% 0% $78
PNC Financial Services Group, Inc. 0% 46 0% $70
Legacy Wealth Managment, LLC/ID 0% 25 0% 0% $39
SBI Securities Co., Ltd. 0% 8 0% 0% $12
RENAISSANCE TECHNOLOGIES LLC 0% 0 -100% $0
Cormorant Asset Management, LP 0% 0 -100% $0
OSAIC HOLDINGS, INC. 0% 0 -100% $0

Institutional Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 10,359 $6,000 +$6,000 57.92% 1
2025 Q3 1,748,895 $2,688,759 -$8,457,377 153% 22
2025 Q2 3,640,815 $17,329,892 -$2,659,834 476% 28
2025 Q1 4,140,775 $23,727,155 +$3,688,830 573% 26
2024 Q4 3,460,017 $24,012,460 +$9,345,855 694% 29
2024 Q3 2,117,088 $12,067,800 +$82,462 570% 26
2024 Q2 2,091,840 $14,831,107 +$10,439,034 709% 27
2024 Q1 542,367 $4,292,372 +$626,559 796.99% 17
2023 Q4 523,990 $3,668,780 +$62,362 700% 21
2023 Q3 513,683 $4,572,074 +$1,116,795 890.01% 24
2023 Q2 380,984 $5,558,799 +$892,556 1,459% 26
2023 Q1 319,440 $4,808,013 -$2,054,856 1,505% 22
2022 Q4 323,590 $12,342,867 +$12,322,867 3,815% 27
2022 Q3 90,500 $20,000 +$20,001 22.1% 1